• 2020年
• 2019年
• 2018年
• 2017年
• 2016年

• 原著
• 共同研究
• 総説
• 症例報告

原著

• Tatsumoto N, Arioka M, Yamada S, Takahashi-Yanaga F, Tokumoto M, Tsuruya K, Kitazono T, Sasaguri T: Inhibition of GSK-3beta increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism.

  Physiol Rep, 4, 2016

• Nakagawa H, Somekawa S, Onoue K, Kumazawa T, Ueda T, Seno A, Nakada Y, Nakano T, Matsui M, Soeda T, Okayama S, Kawakami R, Kawata H, Okura H, Saito Y: Salt accelerates aldosterone-induced cardiac remodeling in the absence of guanylyl cyclase-A signaling.

  Life Sci, 165: 9-15, 2016

• Sakoh T, Nakayama M, Tsuchihashi T, Yoshitomi R, Tanaka S, Katafuchi E, Fukui A, Shikuwa Y, Anzai N, Kitazono T, Tsuruya K: Associations of fibroblast growth factor 23 with urate metabolism in patients with chronic kidney disease.

  Metabolism, 65: 1498-1507, 2016

• Yamada S, Tsuruya K, Taniguchi M, Tokumoto M, Fujisaki K, Hirakata H, Fujimi S, Kitazono T: Association Between Serum Phosphate Levels and Stroke Risk in Patients Undergoing Hemodialysis: The Q-Cohort Study.

  Stroke, 47: 2189-2196, 2016

• Seno A, Takeda Y, Matsui M, Okuda A, Nakano T, Nakada Y, Kumazawa T, Nakagawa H, Nishida T, Onoue K, Somekawa S, Watanabe M, Kawata H, Kawakami R, Okura H, Uemura S, Saito Y: Suppressed Production of Soluble Fms-Like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart Failure.

  Hypertension, 68: 678-687, 2016

• Takae K, Nagata M, Hata J, Mukai N, Hirakawa Y, Yoshida D, Kishimoto H, Tsuruya K, Kitazono T, Kiyohara Y, Ninomiya T: Serum Uric Acid as a Risk Factor for Chronic Kidney Disease in a Japanese Community- The Hisayama Study.

  Circ J, 80: 1857-1862, 2016

• Matsui M, Samejima K, Takeda Y, Morimoto K, Tagawa M, Onoue K, Okayama S, Kawata H, Kawakami R, Akai Y, Okura H, Saito Y: Angiogenic Factors and Risks of Technique Failure and Cardiovascular Events in Patients Receiving Peritoneal Dialysis.

  Cardiorenal Med, 6: 251-259, 2016

• Tanaka S, Ninomiya T, Taniguchi M, Fujisaki K, Tokumoto M, Hirakata H, Ooboshi H, Kitazono T, Tsuruya K: Comparison of oral versus intravenous vitamin D receptor activator in reducing infection-related mortality in hemodialysis patients: the Q-Cohort Study.

  Nephrol Dial Transplant, 31: 1152-1160, 2016

• Washio M, Higashi H, Sugawara K, Tsusumi C, Sakita M, Ide Y, Tsuruya K, Kitazono T, Kondo K, Ide S: Influenza Vaccination and Other Factors Related to the Development of Influenza-Like Illness Among Patients on Chronic Hemodialysis in a Japanese Dialysis Facility.

  Ther Apher Dial, 20: 122-126, 2016

• Yamada S, Tsuruya K, Yoshida H, Tokumoto M, Ueki K, Ooboshi H, Kitazono T: Factors Associated with the Serum Myostatin Level in Patients Undergoing Peritoneal Dialysis: Potential Effects of Skeletal Muscle Mass and Vitamin D Receptor Activator Use.

  Calcif Tissue Int, 99: 13-22, 2016

• Yoshitomi R, Nakayama M, Sakoh T, Fukui A, Shikuwa Y, Tominaga M, Tsuchihashi T, Tsuruya K, Kitazono T: Plasma B-type natriuretic peptide concentration is independently associated with kidney function decline in Japanese patients with chronic kidney disease.

  J Hypertens, 34: 753-761, 2016

• Tsuruya K, Yoshida H, Suehiro T, Fujisaki K, Masutani K, Kitazono T: Erythropoiesis- stimulating agent slows the progression of chronic kidney disease: a possibility of a direct action of erythropoietin.

  Ren Fail, 38: 390-396, 2016

• Yamada S, Tokumoto M, Tatsumoto N, Tsuruya K, Kitazono T, Ooboshi H: Very low protein diet enhances inflammation, malnutrition, and vascular calcification in uremic rats.

  Life Sci, 146: 117-123, 2016

• Eriguchi M, Tsuruya K, Yoshida H, Haruyama N, Tanaka S, Tsuchimoto A, Fujisaki K, Torisu K, Masutani K, Kitazono T: Extended Swan-Neck Catheter With Upper Abdominal Exit-Site Reduces Peritoneal Dialysis-Related Infections.

  Ther Apher Dial, 20: 158-164, 2016

• Masutani K, Tsuchimoto A, Yamada T, Hirakawa M, Mitsuiki K, Katafuchi R, Hirakata H, Kitazono T, Tsuruya K, West Japan Study Group for Therapy of Ig ANI: Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.

  Clin Exp Nephrol, 20: 896-903, 2016

• Eriguchi M, Yotsueda R, Torisu K, Kawai Y, Hasegawa S, Tanaka S, Noguchi H, Masutani K, Kitazono T, Tsuruya K: Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.

  Am J Physiol Renal Physiol, 310: F322-333, 2016

• Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Nagata M, Tsuchimoto A, Hirakata H, Kitazono T, Tsuruya K: The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.

  Clin Exp Nephrol, 20: 689-698, 2016

• Yamada S, Ueki K, Tokumoto M, Suehiro T, Kimura H, Taniguchi M, Fujimi S, Kitazono T, Tsuruya K: Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.

  Ther Apher Dial, 20: 31-39, 2016

共同研究

• Hasegawa K, Tsukamoto K, Kunimi M, Asahi K, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kimura K, Ohashi Y, Watanabe T: Control Status of Atherosclerotic Cardiovascular Risk Factors Among Japanese High-Risk Subjects:Analyses of a Japanese Health Check Database from 2008 to 2011.

  J Atheroscler Thromb, 23: 991-1003, 2016

• Nagasawa Y, Yamamoto R, Shinzawa M, Hasuike Y, Kuragano T, Isaka Y, Nakanishi T, Iseki K, Yamagata K, Tsuruya K, Yoshida H, Fujimoto S, Asahi K, Moriyama T, Watanabe T: Body Mass Index Modifies an Association between Self-Reported Regular Exercise and Proteinuria.

  J Atheroscler Thromb, 23: 402-412, 2016

総説

• Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, Nutahara K, Tsuchiya K, Tsuruya K, Kamura K, Nishio S, Suwabe T, Ubara Y, Ishimura E, Nakanishi K, Furukawa K, Kimura K, Matsuo S: Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014.

  Clin Exp Nephrol, 20: 510, 2016

• Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, Nutahara K, Tsuchiya K, Tsuruya K, Kamura K, Nishio S, Suwabe T, Ubara Y, Ishimura E, Nakanishi K, Furukawa K, Kimura K, Matsuo S: Evidence-based clinical practice guidelines for polycystic kidney disease 2014.

  Clin Exp Nephrol, 20: 493-509, 2016

• Nishi S, Ubara Y, Utsunomiya Y, Okada K, Obata Y, Kai H, Kiyomoto H, Goto S, Konta T, Sasatomi Y, Sato Y, Nishino T, Tsuruya K, Furuichi K, Hoshino J, Watanabe Y, Kimura K, Matsuo S: Evidence-based clinical practice guidelines for nephrotic syndrome 2014.

  Clin Exp Nephrol, 20: 342-370, 2016

• Bernstein KE, Khan Z, Giani JF, Zhao T, Eriguchi M, Bernstein EA, Gonzalez-Villalobos RA, Shen XZ: Overexpression of angiotensin-converting enzyme in myelomonocytic cells enhances the immune response.

  F1000Res, 5, 2016
• Eriguchi M, Tsuruya K: Renal Sympathetic Denervation in Rats. Methods Mol Biol, 1397: 45-52, 2016

症例報告

• Yamasaki K, Haruyama N, Taniguchi M, Nishida T, Tominaga R, Kitazono T, Tsuruya K: Subacute pulmonary embolism in a hemodialysis patient, successfully treated with surgical thrombectomy.

  CEN Case Rep, 5: 74-77, 2016

• Yamada S, Ueki K, Kawai Y, Sako T, Shimomura Y, Tsuchimoto A, Tanaka S, Matsui R, Maeda H, Tokumoto M, Ooboshi H, Kitazono T, Tsuruya K: Extrapulmonary tuberculosis presented as fever of unknown origin in two patients with endstage kidney disease not on dialysis: usefulness of 18-FDG-PET/CT in the diagnostic localization of fever of unknown origin.

  CEN Case Rep, 5: 11-17, 2016

• Hara M, Yamada S, Nakamura Y, Oka H, Kamimura T, Nakane S, Tsuruya K, Harada A: Autoimmune autonomic ganglionopathy manifesting as acute-onset orthostatic hypotension in a patient undergoing peritoneal dialysis.

  CEN Case Rep, 5: 5-10, 2016

• Aihara S, Yamada S, Uchida Y, Arase H, Tsuchimoto A, Nakano T, Taniguchi M, Higashi H, Kitazono T, Tsuruya K: The Successful Treatment of Calciphylaxis with Sodium Thiosulfate and Hyperbaric Oxygen in a Non-dialyzed Patient with Chronic Kidney Disease.

  Intern Med, 55: 1899-1905, 2016

• Hiyamuta H, Yamada S, Matsukuma Y, Tsuchimoto A, Nakano T, Taniguchi M, Masutani K, Yoshimoto G, Muta T, Akashi K, Kitazono T, Tsuruya K: Light Chain Deposition Disease in an Older Adult Patient Successfully Treated with Long-term Administration of Bortezomib, Melphalan and Prednisone.

  Intern Med, 55: 1319-1325, 2016